YLT-LL-11

N/A

Report date: 2022/01/10 10:59:54
NME

Base Information

Drug NameYLT-LL-11
Drug Alias NameYLT-LL-11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAffiliated Hospital Of Southwest Medical University
China Registration ClassN/A

Develop Information

Active CompaniesAffiliated Hospital Of Southwest Medical University
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A